Navigation Links
Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation
Date:8/29/2008

SEATTLE, Aug. 29 /PRNewswire/ -- Attorneys representing consumers in a case accusing McKesson (NYSE: MCK) of illegally rigging the price of virtually every prescription drug have crossed the final procedural hurdles and are now preparing for a trial set for December 1 in U.S. District Court in Boston.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO)

Attorney Steve W. Berman filed the suit in 2006 on behalf of third-party payers and consumers, claiming that McKesson engaged in a scheme to fraudulently inflate the price of more than 400 prescription drugs, including blockbusters such as Prozac, Lipitor, Zocor, Vioxx and more.

On March 18, 2008, Judge Patti Saris for a second time rejected McKesson's motions to dismiss the case, citing the strength of the evidence, which includes volumes of e-mail exchanges by McKesson executives discussing the price-fixing scheme. The plaintiffs in the case peg the damages at $4 billion, which puts McKesson at risk of a $12 billion judgment with the tripling of damages allowed by the RICO statute under which the suits were filed.

RICO -- the Racketeer Influenced and Corrupt Organizations Act -- allows for civil action against those believed to participate in conspiracies to commit crimes or illegally reap profits. The law calls for the disgorgement of ill-gotten profits and the tripling of damages.

Judge Patti Saris earlier this week dismissed a related case charging the drug giant of antitrust violations.

"We believe the antitrust laws were intended to address the sort of disingenuous behavior McKesson exhibited, but we recognize that the allegations presented a context not directly addressed by prior case-law," Berman said. "We understand and appreciate Judge Saris' ruling, and are eager to move forward with the strongest case -- the RICO charges."

The case represents two classes: consumer purchasers, which includes anyone who made a co-payment for prescription medication from August 1, 2001 through May 15, 2005, and all third-party payers that made a payment or reimbursement based on the inflated average wholesale price (AWP) during the class period.

The suit claims McKesson and First DataBank, a publishing company, reached a secret agreement on how the average wholesale price would be set for brand-name drugs and, in doing so, raised the spread between the published AWP and the actual acquisition costs from 20 to 25 percent in an effort to increase profits.

Earlier this year, First DataBank settled with plaintiffs, leaving McKesson as the sole defendant.

According to documents cited in the case, McKesson communicated the price increase to First DataBank, who published the information, even amid questions by manufacturers who recognized the impact to consumers and third-party payers. McKesson did so to raise the profits for its large clients like Rite Aid and Walgreen's.

For more information on this case and to sign up as a consumer or third-party payer you can visit the Hagens Berman Web site at http://www.hbsslaw.com.

About Hagens Berman Sobol Shapiro

Hagens Berman Sobol Shapiro, is based in Seattle with offices in Chicago, Cambridge, Los Angeles, Phoenix, San Francisco and New York. Since 1993, it has developed a nationally recognized practice in class-action and complex litigation. Among recent successes, HBSS has negotiated a $300 million settlement in the DRAM memory antitrust litigation, one of the largest anti-trust settlements in history; a $340 million recovery on behalf of Enron employees; a $150 million settlement involving charges of illegally inflated charges for the drug Lupron, and served as co-counsel on the Visa/Mastercard litigation which resulted in a $3 billion settlement, the largest anti-trust settlement to date. HBSS served as counsel in a $850 million Washington Public Power Supply settlement and represented Washington and 12 other states against the tobacco industry that resulted in the largest settlement in history. For a complete listing of HBSS cases, visit http://www.hbsslaw.com.

CONTACT:

Steve Berman (206) 623-7292 Mark Firmani (206) 919-9357

Hagens Berman Sobol Shapiro Firmani + Associates Inc.

Steve@hbsslaw.com Mark@firmani.com


'/>"/>
SOURCE Hagens Berman Sobol Shapiro
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
2. Gunther von Hagens BODY WORLDS Exhibitions Welcome Specimens From Worlds First Living Body Donor for Plastination
3. Gunther Von Hagens BODY WORLDS Exhibitions Mark 25th Million Visitor Milestone
4. Hagens Berman Sobol Shapiro: Nationwide Class Action Certified in Average Wholesale Price Litigation
5. Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation
6. Anatomist Dr. Gunther von Hagens Clarifies: Plastinates Not For Sale
7. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
8. Hagens Berman Sobol Shapiro Announces Investigation Into Marketing of Vytorin and Zetia
9. Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case
10. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
11. Social Security Attorneys Prepare for Increased Baby Boomer SSI Claims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between Goodwill® and Roadie, ... use or need, from clothes to couches to dressers and bicycles. Roadie — the ... to the nearest Goodwill donation center through February 28th. , “January is an ...
(Date:1/20/2017)... ... 2017 , ... Bionic Sports Nutrition LLC, an American company devoted to developing ... successful January ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition ... provide its products to all clients at reasonable prices. At the ECRM trade show, ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated ... Institute. For Betsy, the clinical trial has been life-saving as she has been ... , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and ... out for each of his children. “The Angel” is the creation of published author, ... New York City, and impassioned writer. , When asked of her new book, Marjorie ...
(Date:1/20/2017)... ... ... “Christmas in Suffolk”: a story of love, secrets, and mystery. “Christmas in ... where she works in a daycare and looks for inspiration in the local coffee ... Publishing, Sara Seymour’s new book is an adventure of love and secrets. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017 The global immunomodulators market is ... according to a new study by Grand View ... predominantly driven by high R&D investments employed by ... of new and therapeutically advanced drugs. This is ... an unprecedented rate into the immunomodulators market hence ...
(Date:1/19/2017)... 2017 Conference Call and Webcast to Follow ... it will release results for the fourth quarter of 2016 on ... ... call at 4:30 PM ET on Wednesday, February 15, 2017, during ... financial results and other corporate activities. To participate in the conference ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
Breaking Medicine Technology: